LITSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$30.878 M
$0.91 -2.31%
Close of 7 Aug 2026
Revenue
$0.00
#3658 by revenue
Earnings
-$15.9M
Loss-making
Shares outstanding
34,025,200
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations — ranked by market cap
All 501 →Where these numbers come from
Share counts and financials for Lite Strategy are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.